You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 17, 2024

CLINICAL TRIALS PROFILE FOR CLONIDINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Clonidine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000279 ↗ Novel Medications for Opiate Detoxification - 4 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-09-01 The purpose of this study is to evaluate novel medications for opiate detoxification.
NCT00000279 ↗ Novel Medications for Opiate Detoxification - 4 Completed VA Connecticut Healthcare System Phase 2 1994-09-01 The purpose of this study is to evaluate novel medications for opiate detoxification.
NCT00000279 ↗ Novel Medications for Opiate Detoxification - 4 Completed Yale University Phase 2 1994-09-01 The purpose of this study is to evaluate novel medications for opiate detoxification.
NCT00000800 ↗ Methadone Effects on Zidovudine (ZDV, AZT) Disposition Completed Glaxo Wellcome Phase 1 1969-12-31 To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination.
NCT00000800 ↗ Methadone Effects on Zidovudine (ZDV, AZT) Disposition Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 1 1969-12-31 To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination.
NCT00003771 ↗ Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer Completed European Organisation for Research and Treatment of Cancer - EORTC Phase 3 1997-09-01 RATIONALE: Hormone replacement therapy is effective for relieving symptoms of menopause. It is not yet known if hormone replacement therapy increases the risk of breast cancer recurrence in women previously treated for early stage breast cancer. PURPOSE: Randomized phase III trial to determine the risk of breast cancer recurrence in women with previous early stage breast cancer who are receiving hormone replacement therapy for menopause symptoms.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Clonidine

Condition Name

Condition Name for Clonidine
Intervention Trials
Postoperative Pain 18
Hypertension 15
Pain 14
Pain, Postoperative 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Clonidine
Intervention Trials
Pain, Postoperative 41
Delirium 17
Hypertension 15
Opioid-Related Disorders 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Clonidine

Trials by Country

Trials by Country for Clonidine
Location Trials
United States 251
Egypt 44
France 19
Brazil 16
Canada 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Clonidine
Location Trials
New York 22
Texas 16
Maryland 16
California 15
North Carolina 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Clonidine

Clinical Trial Phase

Clinical Trial Phase for Clonidine
Clinical Trial Phase Trials
Phase 4 113
Phase 3 52
Phase 2/Phase 3 14
[disabled in preview] 96
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Clonidine
Clinical Trial Phase Trials
Completed 196
Recruiting 49
Not yet recruiting 37
[disabled in preview] 76
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Clonidine

Sponsor Name

Sponsor Name for Clonidine
Sponsor Trials
National Institute on Drug Abuse (NIDA) 15
Assiut University 15
Johns Hopkins University 9
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Clonidine
Sponsor Trials
Other 496
Industry 40
NIH 32
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.